AGP Executive Report
Last update: 10 hours agoSleep & Brain Health: Iceland researchers report that sleep apnea and low-oxygen sleep can slow adults’ ability to recognize facial emotions, adding to concerns that disrupted sleep affects more than breathing. Public Health & Policy: The European Commission has authorized expanded first-line use of AbbVie’s VENCLYXTO (venetoclax) in combination regimens for chronic lymphocytic leukemia, with access extended to Iceland, Norway and Liechtenstein. Health Tech / Ophthalmology: Oculis released topline Phase 3 DIAMOND results for OCS-01 eye drops in diabetic macular edema, saying the primary endpoint wasn’t met but retinal thickness improved persistently. Wellness & Lifestyle: A new study suggests obesity rates are leveling off in many countries, with some cautious optimism—especially where child trends are shifting. Environment & Health Risk: Mosquitoes have been found in Iceland for the first time ever after unusually warm spring weather, raising alarm about climate-driven disease risk. Care Access: The UK DWP confirmed strict holiday rules for PIP claimants, warning that long trips can affect entitlement.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
